Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 1.0
Dare Bioscience, Inc. issued 20,000 Investor Units, each consisting of one share of Series A Convertible Preferred Stock and two warrants to purchase one share of common stock of unit to investors in the Regulation A offering for $5.00 per unit.
- Security
- unit
- Shares
- 20,000 Investor Units, each consisting of one share of Series A Convertible Preferred Stock and two warrants to purchase one share of common stock
- Purchaser
- investors in the Regulation A offering
- Consideration
- $5.00 per unit
Exact text from the filing
On April 17, 2026, Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) completed a closing of our previously announced Regulation A offering of up to 4,854,000 units (each, an “Investor Unit” and collectively the “Investor Units”), each consisting of one share of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) and two warrants, each to purchase one share of our common stock (“Investor Warrants”), with each Investor Unit being offered at an offering price of $5.00 (the “Offering”). In connection therewith, we issued an aggregate of 20,000 Investor Units consisting of 20,000 shares of Series A Preferred Stock and Investor Warrants to purchase up to 40,000 shares of our common stock.
View on SEC.gov